Nano Medtech

Nano Medtech

They have engineered polylactic-co-glycolic acid (PLGA) immunonanoparticles specifically for targeting invasive epithelial tumour cells.

This company is working on the base of traditional Chinese medicine. They focuses on human application of nano-technology, especially in the area of cancer treatment. Monoclonal antibody (mAb) are used as a homing ligand and attached to the nanoparticle surface either covalently or non-covalently as required. Protein assay, surface plasmon resonance Nanoparticle mAb binding MCF-10A neoT cell targeting Caco-2 cells immunonanoparticles Immunostaining Monitoring. As they say:  "Specific targeting of generic malignant cells or tissue is now possible through the utilization of immuno-nanoparticles. Nano Robots / nanoparticles by which mAbs can be bound without detriment to their targeting ability, shows an applied effectiveness as a new carrier system for the delivery of small or large active substances into cells or tissues of interests."

Business Type: Nanotextile » | Biotechnology » | Electrotechnics » |

Nano Medtech

1001 Tian Lin Road, Caohejin, Hi-Tech Park
200233 Shanghai


Share with friends:  

Next companies in category